Want to join the conversation?
$TMK 2Q15 Call: Premium revenue for Medicare Part D declined 11% to $75MM. The underwriting margin for second quarter 2015 was $5MM, down from $9MM. The decline in underwriting margin was in line with our expectations was due to the increase in the Part D Drug costs. Net sales were $11MM, compared to $20MM in the year-ago quarter.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.